Pharmacological treatment of generalized anxiety disorder

Duration of Untreated Illness as a Predictor of Treatment Response and Clinical Course in Generalized Anxiety Disorder

(2016) A. Carlo Altamura et al.   CNS SPECTRUMS

Time to Relapse After 6 and 12 Months' Treatment of Generalized Anxiety Disorder With Venlafaxine Extended Release

(2010) Karl Rickels et al.   ARCHIVES OF GENERAL PSYCHIATRY

Use of duloxetine in patients with an anxiety disorder, or with comorbid anxiety and major depressive disorder: a review of the literature

(2010) Michele Mancini et al.   EXPERT OPINION ON PHARMACOTHERAPY

Ziprasidone Treatment of Refractory Generalized Anxiety Disorder

(2010) Falk W. Lohoff et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Escitalopram for Persistent Symptoms of Generalized Anxiety Disorder After CBT

(2010) Franklin R. Schneier et al.   JOURNAL OF NERVOUS AND MENTAL DISEASE

Adjunctive Use of Atypical Antipsychotics for Treatment-Resistant Generalized Anxiety Disorder

(2010) Raymond A Lorenz et al.   PHARMACOTHERAPY

Randomized, single-blind, trial of sertraline and buspirone for treatment of elderly patients with generalized anxiety disorder

(2010) Naghmeh Mokhber et al.   PSYCHIATRY AND CLINICAL NEUROSCIENCES

Antidepressant-induced jitteriness/anxiety syndrome: systematic review

(2009) Lindsey I. Sinclair et al.   BRITISH JOURNAL OF PSYCHIATRY

Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies

(2009) C. Barbui et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Current Considerations in the Treatment of Generalized Anxiety Disorder

(2009) Martin A. Katzman   CNS DRUGS

Novel approaches to treatment of generalized anxiety disorder

(2009) Christer Allgulander   CURRENT OPINION IN PSYCHIATRY

Atypical antipsychotics in primary generalized anxiety disorder or comorbid with mood disorders

(2009) Keming Gao et al.   Expert Review of Neurotherapeutics

Long-term efficacy of pregabalin in generalized anxiety disorder

(2009) Douglas Feltner et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

The efficacy of pregabalin and benzodiazepines in generalized anxiety disorder presenting with high levels of insomnia

(2009) Stuart A. Montgomery et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive–compulsive disorder: a 12-week open-label preliminary study

(2009) Enrico Pessina et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

Extended-release quetiapine fumarate (quetiapine XR): a once-daily monotherapy effective in generalized anxiety disorder. Data from a randomized, double-blind, placebo- and active-controlled study

(2009) Borwin Bandelow et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Optimized Antidepressant Therapy and Pain Self-management in Primary Care Patients With Depression and Musculoskeletal Pain

(2009) Kurt Kroenke et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Physician Withdrawal Checklist (PWC-20)

(2009) Karl Rickels et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

The relationship between functional outcomes and the treatment of anxious and painful somatic symptoms in patients with generalized anxiety disorder

(2008) David V. Sheehan et al.   CURRENT MEDICAL RESEARCH AND OPINION

Tiagabine in Adult Patients With Generalized Anxiety Disorder

(2008) Mark H. Pollack et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Early improvement during duloxetine treatment of generalized anxiety disorder predicts response and remission at endpoint

(2008) Mark H. Pollack et al.   JOURNAL OF PSYCHIATRIC RESEARCH

Examining quality of life in patients with generalized anxiety disorder: Clinical relevance and response to duloxetine treatment

(2008) Mark H. Pollack et al.   JOURNAL OF PSYCHIATRIC RESEARCH

A non-inferiority comparison of duloxetine and venlafaxine in the treatment of adult patients with generalized anxiety disorder

(2008) C Allgulander et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Improvement of psychic and somatic symptoms in adult patients with generalized anxiety disorder: examination from a duloxetine, venlafaxine extended-release and placebo-controlled trial

(2008) H. Nicolini et al.   PSYCHOLOGICAL MEDICINE

Quetiapine augmentation of paroxetine CR for the treatment of refractory generalized anxiety disorder: preliminary findings

(2008) Naomi M. Simon et al.   PSYCHOPHARMACOLOGY

Efficacy of duloxetine in the treatment of generalized anxiety disorder in patients with clinically significant pain symptoms

(2007) James M. Russell et al.   DEPRESSION AND ANXIETY

Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial

(2007) Moira Rynn et al.   DEPRESSION AND ANXIETY

Valproate (depakine-chrono) in the acute treatment of outpatients with generalized anxiety disorder without psychiatric comorbidity: Randomized, double-blind placebo-controlled study

(2007) Nadir A. Aliyev et al.   EUROPEAN PSYCHIATRY